The Technology Co.,Ltd. Stock

Equities

A043090

KR7043090000

Industrial Machinery & Equipment

End-of-day quote Korea S.E. 06:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
426 KRW -5.33% Intraday chart for The Technology Co.,Ltd. -6.78% -33.44%
Sales 2022 3.9B 2.83M Sales 2023 15.89B 11.54M Capitalization 37.84B 27.47M
Net income 2022 -3.34B -2.43M Net income 2023 -27.11B -19.68M EV / Sales 2022 19.6 x
Net cash position 2022 19.07B 13.85M Net Debt 2023 4M 2.91K EV / Sales 2023 2.38 x
P/E ratio 2022
-23.3 x
P/E ratio 2023
-1.31 x
Employees 21
Yield 2022 *
-
Yield 2023
-
Free-Float 92.45%
More Fundamentals * Assessed data
Dynamic Chart
PangSky Corp. announced that it has received KRW 1 billion in funding from Exergy21 Co., Ltd. CI
PangSky Corp. announced that it expects to receive KRW 1 billion in funding from Exergy21 Co., Ltd. CI
Exergy21 Co., Ltd. announced that it expects to receive KRW 24.999999475 billion in funding CI
Kattus Co., Ltd. announced that it has received KRW 5.999 billion in funding from Exergy21 Co., Ltd. CI
Kattus Co., Ltd. announced that it expects to receive KRW 5.999 billion in funding from Exergy21 Co., Ltd. CI
Exergy21 Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Exergy21 Co., Ltd. announced that it expects to receive KRW 25 billion in funding CI
Hanchang Biotech Co., Ltd. announced that it has received KRW 15 billion in funding from Exergy21.Inc CI
HanChang Biotech to Raise $9.2 Million Through Stock Offering MT
Hanchang Corporation entered into an agreement to acquire 73.98% for KRW 25 billion. CI
Exergy21 Co., Ltd. announced that it expects to receive KRW 79.99999938 billion in funding from Jeonheung CNC Co., Ltd. CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 12.5 billion in funding from Jeonheung CNC Co., Ltd. CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 15 billion in funding from Exergy21.Inc CI
An undisclosed buyer agreed to acquire 8.6% stake in Hanchang Biotech Co., Ltd. from Hanchang Corporation for KRW 6.8 billion. CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 27.49999938 billion in funding CI
More news
1 day-5.33%
1 week-6.78%
Current month-14.11%
1 month-14.63%
3 months-8.97%
6 months-31.73%
Current year-33.44%
More quotes
1 week
426.00
Extreme 426
476.00
1 month
426.00
Extreme 426
570.00
Current year
386.00
Extreme 386
705.00
1 year
386.00
Extreme 386
2 655.00
3 years
386.00
Extreme 386
5 280.00
5 years
386.00
Extreme 386
5 280.00
10 years
386.00
Extreme 386
8 990.00
More quotes
Members of the board TitleAgeSince
Director/Board Member 54 -
More insiders
Date Price Change Volume
24-04-25 426 -5.33% 220,104
24-04-24 450 +0.90% 196,236
24-04-23 446 -3.04% 52,574
24-04-22 460 -0.43% 39,288
24-04-19 462 +1.09% 134,334

End-of-day quote Korea S.E., April 24, 2024

More quotes
The Technology Co Ltd, formerly Exergy21 Co Ltd, is a Korea-based company mainly engaged in the distribution business. The Company manly operates its business through four segments. The Distribution Business segment engages in the food processors, luxury goods, healthy food, kitchen appliances and home shopping goods distribution business. The PM business segment provides consulting services for real estate development, licensing, and contractor selection. The Pharmaceutical segment engages in ethanol and disinfectant manufacture business. The Other segment provides business support services. The Company also engages in information technology (IT) services, artificial intelligence (AI) and drone based security solutions, as well as heat pump system provision business.
More about the company
  1. Stock Market
  2. Equities
  3. A043090 Stock